Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aiko Murayama

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Hepatocellular Carcinoma|October 29, 2020
Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial ChemoembolizationSaito Kobayashi, Kazuto Tajiri, Aiko Murayama, et al.
Internal Medicine (Tokyo, Japan)|July 3, 2024
Wilson's Disease Suspected to Involve a Novel Genetic Mutation of ATP7B Gene, Requiring a Differential Diagnosis with Non-alcoholic SteatohepatitisMasami Minemura, Rei Fukuda, Kazuto Tajiri, et al.
Case Reports in Gastroenterology|October 7, 2021
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor TreatmentAiko Murayama, Kazuto Tajiri, Atsuko Nakaya, et al.
Oncology|September 4, 2023
Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular CarcinomaKazuto Tajiri, Kenichiro Tsukada, Yoshiharu Tokimitsu, et al.
World Journal of Hepatology|August 18, 2022
Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinomaKazuto Tajiri, Hiroyuki Ito, Kengo Kawai, et al.
Case Reports in Gastroenterology|February 29, 2020
Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular CarcinomaNaomi Suzuki, Kazuto Tajiri, Yuka Futsukaichi, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus InfectionYuka Hayashi, Kazuto Tajiri, Tatsuhiko Ozawa, et al.
Anticancer Research|December 1, 2022
Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort StudyKazuto Tajiri, Yoshiharu Tokimitsu, Kengo Kawai, et al.
BMC Gastroenterology|May 25, 2023
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antiviralsKazuto Tajiri, Kazuhiko Okada, Hiroyuki Ito, et al.
Frontiers in Oncology|October 4, 2023
Liver metastasis affects progression pattern during immune checkpoint inhibitors monotherapy in gastric cancerIori Motoo, Takayuki Ando, Takeru Hamashima, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Hepatocellular Carcinoma|October 29, 2020
Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial ChemoembolizationSaito Kobayashi, Kazuto Tajiri, Aiko Murayama, et al.
Internal Medicine (Tokyo, Japan)|July 3, 2024
Wilson's Disease Suspected to Involve a Novel Genetic Mutation of ATP7B Gene, Requiring a Differential Diagnosis with Non-alcoholic SteatohepatitisMasami Minemura, Rei Fukuda, Kazuto Tajiri, et al.
Case Reports in Gastroenterology|October 7, 2021
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor TreatmentAiko Murayama, Kazuto Tajiri, Atsuko Nakaya, et al.
Oncology|September 4, 2023
Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular CarcinomaKazuto Tajiri, Kenichiro Tsukada, Yoshiharu Tokimitsu, et al.
World Journal of Hepatology|August 18, 2022
Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinomaKazuto Tajiri, Hiroyuki Ito, Kengo Kawai, et al.
Case Reports in Gastroenterology|February 29, 2020
Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular CarcinomaNaomi Suzuki, Kazuto Tajiri, Yuka Futsukaichi, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus InfectionYuka Hayashi, Kazuto Tajiri, Tatsuhiko Ozawa, et al.
Anticancer Research|December 1, 2022
Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort StudyKazuto Tajiri, Yoshiharu Tokimitsu, Kengo Kawai, et al.
BMC Gastroenterology|May 25, 2023
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antiviralsKazuto Tajiri, Kazuhiko Okada, Hiroyuki Ito, et al.
Frontiers in Oncology|October 4, 2023
Liver metastasis affects progression pattern during immune checkpoint inhibitors monotherapy in gastric cancerIori Motoo, Takayuki Ando, Takeru Hamashima, et al.
Pageof 2